Glitaray MP 2mg/500mg/15mg Tablet PR
Marketer
Lloyd Healthcare Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glitaray MP 2mg/500mg/15mg Tablet PR
Glarin-MP, a 2mg/500mg/15mg tablet, is a triple-combination medication designed to manage blood glucose. This therapy, used in conjunction with diet and exercise, improves glycemic control for adults with type 2 diabetes. It enhances insulin effectiveness, consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen for Glarin-MP. Taking it with food minimizes stomach discomfort. If a dose is missed, take it immediately; however, if the next dose is imminent, omit the missed dose and resume your normal schedule. Never double the dose. An overdose can result in hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or skipped meals may trigger hypoglycemia. Regular blood glucose monitoring is essential. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating women should seek medical counsel before use. Kidney function tests will be performed before treatment commences. Limit alcohol consumption as it may exacerbate side effects.
Primary Ingredients of Glitaray MP 2mg/500mg/15mg Tablet PR
No text provided. Please provide the text you want me to rephrase.
Uses of Glitaray MP 2mg/500mg/15mg Tablet PR
Managing type 2 diabetes
Major Benefits of Glitaray MP 2mg/500mg/15mg Tablet PR:
Follow your physician's instructions or consult the product information leaflet for dosage guidance. Administer Glitaray MP 2mg/500mg/15mg Tablet PR with a meal.
Common Side effects of Glitaray MP 2mg/500mg/15mg Tablet PR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glitaray MP 2mg/500mg/15mg Tablet PR:
Follow your physician's instructions or consult the product information leaflet for proper administration. Consume Glitaray MP 2mg/500mg/15mg Tablet PR with a meal.
How Glitaray MP 2mg/500mg/15mg Tablet PR works:
Glitaray MP 2mg/500mg/15mg tablets are a triple-combination therapy containing glimepiride, metformin, and pioglitazone. These antidiabetic agents utilize distinct mechanisms to enhance glycemic control when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, enhances insulin sensitivity, further aiding blood sugar management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glitaray MP 2mg/500mg/15mg Tablet PR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glitaray MP 2mg/500mg/15mg Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glitaray MP 2mg/500mg/15mg Tablet PR while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glitaray MP 2mg/500mg/15mg Tablet PR cautiously, potentially requiring dosage modification. Physician consultation is advised. The use of Glitaray MP 2mg/500mg/15mg Tablet PR is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Glitaray MP 2mg/500mg/15mg Tablet PR. Dosage modification of Glitaray MP 2mg/500mg/15mg Tablet PR may be necessary; physician consultation is advised. Glitaray MP 2mg/500mg/15mg Tablet PR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glitaray MP 2mg/500mg/15mg Tablet PR :
Should you forget to take a Glitaray MP 2mg/500mg/15mg Tablet PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glitaray MP 2mg/500mg/15mg Tablet PR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |


